Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration - Université d'Évry Access content directly
Journal Articles Nature Communications Year : 2018

Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration

Fanny Collaud
Giuseppe Ronzitti
Christian Leborgne
Severine Charles
  • Function : Author
Giorgia Manni
  • Function : Author
Christopher Roy
  • Function : Author
Alicia Michaud
  • Function : Author
Petr Ilyinskii
  • Function : Author
Takashi Kei Kishimoto
  • Function : Author

Abstract

Gene therapy mediated by recombinant adeno-associated virus (AAV) vectors is a promising treatment for systemic monogenic diseases. However, vector immunogenicity represents a major limitation to gene transfer with AAV vectors, particularly for vector re-administration. Here, we demonstrate that synthetic vaccine particles encapsulating rapamycin (SVP[Rapa]), co-administered with AAV vectors, prevents the induction of anti-capsid humoral and cell-mediated responses. This allows successful vector re-administration in mice and nonhuman primates. SVP[Rapa] dosed with AAV vectors reduces B and T cell activation in an antigen-selective manner, inhibits CD8+ T cell infiltration in the liver, and efficiently blocks memory T cell responses. SVP[Rapa] immunomodulatory effects can be transferred from treated to naive mice by adoptive transfer of splenocytes, and is inhibited by depletion of CD25+ T cells, suggesting a role for regulatory T cells. Co-administration of SVP[Rapa] with AAV vector represents a powerful strategy to modulate vector immunogenicity and enable effective vector re-administration.
Fichier principal
Vignette du fichier
41467_2018_Article_6621.pdf (2.57 Mo) Télécharger le fichier
Origin Publisher files allowed on an open archive

Dates and versions

hal-02177709 , version 1 (05-12-2023)

Identifiers

Cite

Florence Boisgérault, Amine Meliani, Romain Hardet, Solenne Marmier, Fanny Collaud, et al.. Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration. Nature Communications, 2018, 9 (1), pp.4098. ⟨10.1038/s41467-018-06621-3⟩. ⟨hal-02177709⟩
151 View
15 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More